Sunniva (CNSX:SNN) Trading Down 10.7%

Share on StockTwits

Sunniva Inc (CNSX:SNN)’s share price was down 10.7% on Friday . The company traded as low as $0.13 and last traded at $0.13, approximately 117,164 shares changed hands during trading. An increase of 164% from the average daily volume of 44,398 shares. The stock had previously closed at $0.14.

The firm has a 50-day simple moving average of $0.17 and a 200-day simple moving average of $0.60.

Sunniva Company Profile (CNSX:SNN)

Sunniva Inc, through its subsidiaries, operates as a vertically integrated medical cannabis company in California and Canada. The company focuses on producing medical cannabis; and converting trim to extracted products, such as cannabis oil. It also owns and operates a network of 7 clinics in Canada specializing in medical cannabis; and provides custom, private-label vaporizers serving approximately 80 brands in the North American marketplace.

Featured Story: Stock Selection – What is cash flow?

Receive News & Ratings for Sunniva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sunniva and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Wesbanco Bank Inc. Raises Stake in SPDR Gold Shares
Wesbanco Bank Inc. Raises Stake in SPDR Gold Shares
Atlanta Capital Management Co. L L C Raises Position in 3M Co
Atlanta Capital Management Co. L L C Raises Position in 3M Co
Princeton Portfolio Strategies Group LLC Acquires 167 Shares of JPMorgan Chase & Co.
Princeton Portfolio Strategies Group LLC Acquires 167 Shares of JPMorgan Chase & Co.
Sontag Advisory LLC Has $1.34 Million Stock Holdings in Gilead Sciences, Inc.
Sontag Advisory LLC Has $1.34 Million Stock Holdings in Gilead Sciences, Inc.
Wesbanco Bank Inc. Has $1.83 Million Stake in Automatic Data Processing
Wesbanco Bank Inc. Has $1.83 Million Stake in Automatic Data Processing
JPMorgan Chase & Co.  Shares Sold by Cidel Asset Management Inc.
JPMorgan Chase & Co. Shares Sold by Cidel Asset Management Inc.


 
© 2006-2020 Zolmax.